LUCÍLIA SARAIVA, PhD

Degree in Pharmaceutical Sciences and PhD in Pharmacology. Assistant Professor at the Department of Biological Sciences, Faculty of Pharmacy, University of Porto. Expertise in Pharmacology, Microbial Biotechnology, Oncobiology and Molecular Biology. She has been focused on the study of the biology and pharmacology of p53 and PKC family proteins, as well as on understanding crucial events underlying cancer pathobiology. During the last years, she has been responsible for the discovery of new targeted-anticancer therapies through the development of innovative screening approaches involving yeast, human tumor cells and animal models, including a selective small-molecule activator of PKCdelta (international patent request), two new inhibitors of the p53-MDM2 interaction, two new dual inhibitors of the p53-MDM2/X interactions, and two reactivators of mutant p53 (International patent).